Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G VivasGynaecological health — menstrual disorders and androgen excess

O&G Vivas · Gynaecological health — menstrual disorders and androgen excess

Polycystic ovary syndrome — structured oral station (12 minutes)

FRANZCOG oral-format station on polycystic ovary syndrome: candidate applies the Rotterdam criteria with exclusion of mimics, places letrozole first-line for fertility with the PPCOS evidence, screens for glucose intolerance and depression, and counsels on a whole-life condition. Scored against the eight published RANZCOG oral domains.

clinical3 min readVerification in progress

Target exams

FRANZCOGMRCOGABOG
On this page
Study tools

Target exams

FRANZCOGMRCOGABOG
Prompt
A 27-year-old woman presents with irregular cycles (every 40 to 60 days), hirsutism, and difficulty losing weight. She and her partner have been trying to conceive for 12 months. Her BMI is 31. The examiner will ask you to establish the diagnosis, outline the metabolic and fertility management, and communicate with her about this lifelong condition.

Station format

4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply to every station: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport with patient, support person or colleague; respect; communication skills. You are being marked on how you behave, not only what you know. [1]

Reveal the examiner script and model responsesShowHide

Opening prompt — "How do you establish the diagnosis?"

Model response — say it in this order: [1][2]

  • "I would apply the Rotterdam criteria: any two of three — oligo/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology or elevated anti-Mullerian hormone — after exclusion of mimics. She has oligomenorrhoea and hirsutism, so she already meets two of three."[1]
  • "Crucially, PCOS is a diagnosis of exclusion. I would send a morning 17-hydroxyprogesterone to exclude non-classic congenital adrenal hyperplasia, plus TSH and prolactin, and a calculated free testosterone or free androgen index."[6]
  • "I would only request a transvaginal ultrasound if I needed a third criterion — it is not required when two are already present."[2]

Examiner is listening for: two of three, after exclusion, and the specific exclusion tests.

Probe 1 — "Her glucose tolerance test shows impaired glucose tolerance. What does that mean for her?"

  • "Women with PCOS have a markedly higher prevalence of impaired glucose tolerance — the Kakoly meta-analysis found an OR of 3.26, and type 2 diabetes an OR of 2.87, versus controls, with the highest prevalence in Asian populations."[4]
  • "So lifestyle intervention is first-line and foundational — energy-restricted eating and regular physical activity improve insulin sensitivity. I would also protect her endometrium, since her cycles are over 40 days and anovulation means unopposed oestrogen."[2]

Probe 2 — "She wants to conceive. What is your fertility plan?"

  • "Lifestyle optimisation first, then letrozole as first-line ovulation induction, with ovulation tracking."[2]
  • "The evidence is the PPCOS trial: letrozole achieved a higher cumulative live birth rate than clomiphene — 27.5% versus 19.1% (rate ratio 1.44, 95% CI 1.10 to 1.87) — with a higher ovulation rate (61.7% versus 48.3%). The 2023 International Guideline made letrozole first-line on this basis."[3]
  • "If letrozole fails, I would move to low-dose gonadotrophins with OHSS mitigation, then laparoscopic ovarian drilling or IVF with an OHSS-prevention protocol — PCOS carries a higher OHSS risk."[2]

Probe 3 — "She asks whether metformin will help her conceive."

  • "The Endocrine Society guideline is clear that metformin is beneficial for metabolic and glycaemic features but has no benefit in treating infertility. So I would not offer it as a fertility drug."[6]
  • "It may have a role as an adjunct for her glucose intolerance alongside lifestyle, but letrozole is the fertility agent."[6]

Probe 4 — "She is tearful and says she feels unfeminine and depressed."

This is a scored domain, not a courtesy. Demonstrate it out loud: [5]

  • Acknowledge her distress at eye level: "What you are feeling is very common in PCOS, and it is not your fault. Let's make sure we look after your mood as well as your cycles."
  • "The Cooney meta-analysis found women with PCOS have about a 3.78-fold higher odds of depressive symptoms and a 5.62-fold higher odds of anxiety. I would screen with a validated tool like the PHQ-9 and GAD-7 and refer to psychological support."[5]
  • Avoid minimising her appearance concerns and avoid framing the diagnosis around weight alone.[2]

Probe 5 — "What will you do for her long-term?"

  • "PCOS is a lifelong condition managed by life stage, not cured. I would arrange periodic glucose tolerance testing, lipids, blood pressure and weight surveillance, and ongoing mood screening."[2]
  • "I would coordinate her care with a multidisciplinary team — gynaecology, endocrinology, dietitian, psychology, and primary care."[2]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril, 2004.PMID 14711538
  2. [2]Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome Fertil Steril, 2023.PMID 37589624
  3. [3]Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome N Engl J Med, 2014.PMID 25006718
  4. [4]Kakoly NS, Khomami MB, Joham AE, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression Hum Reprod Update, 2018.PMID 29590375
  5. [5]Cooney LG, Lee I, Sammel MD, Dokras A High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod, 2017.PMID 28333286
  6. [6]Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab, 2013.PMID 24151290
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPolycystic ovary syndrome — structured oral station (12 minutes)Gynaecological health — menstrual disorders and androgen excessNextPost-operative complications — structured oral station (12 minutes)Perioperative care — post-operative complications